Payer

Bright Health Group reported massive enrollment growth across its commercial, Medicare Advantage and value-based lines, but recorded a net loss of more than $180 million in the quarter ending March 31, according to its first-quarter earnings report released May 4.

Payers and pharmacy benefit managers say specialty drugs now account for 50 percent or more of the total prescription spending they manage, Forbes reported May 3. 

With an estimated 65 million Americans covered under value-based care plans by 2025, payers are making big investments in care delivery models that focus on quality over quantity. From partnerships with providers to billion-dollar purchases of home care services, these…

Bingham Farms, Mich.-based United Physicians and Agilon Health have entered a long-term partnership to transition United's primary care delivery system for Medicare Advantage patients to a full-risk value-based care model.

Portland, Maine-based Fore River Urology is terminating its contract with Anthem, Maine Public Radio reported May 2. 

Government Accountability Office head Gene Dodaro appointed four new members to the Medicaid and CHIP Payment and Access Commission May 2. 

Four House lawmakers said it is "well past time to bring prior authorization into the 21st century," following an HHS report on Medicare Advantage denials.

Centene CEO Sarah London addressed alleged issues with Magellan's Medicaid pharmacy benefits rollout in January during the company's first-quarter earnings call April 26.

UnitedHealthcare plans will only pay for the controversial Alzheimer's drug Aduhelm for patients in clinical trials who have received prior authorization, according to a medical policy update filed May 1.

The Massachusetts Supreme Court approved a $236 million merger between UnitedHealth Group subsidiary Optum and Atrius Health on April 29, Atrius Health confirmed to Becker's.